Please select a region
Please select a region
中文 
English
最新的帖子
八月 21, 2018
NASH: The Silent Liver Disease
With the prevalence of Non-alcoholic Steatohepatitis (NASH) rapidly increasing globally, West is working with its pharmaceutical partners to support their development of new injectable treatments for this serious liver condition. However, there are many challenges associated with trying to bring new treatments to market.<br />
以前的博客
